| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/02/2014 | US20140005123 Pharmaceutical compositions |
| 01/02/2014 | US20140005122 Gemcitabine combination therapy |
| 01/02/2014 | US20140005120 Activity Enhancer for Anticancer Agent |
| 01/02/2014 | US20140005116 Keloid treatment |
| 01/02/2014 | US20140005113 Treatment of disorders with altered vascular barrier function |
| 01/02/2014 | US20140005112 Method of treating chronic heart failure by administering relaxin |
| 01/02/2014 | US20140005111 Injectable delivery system for heparan-binding growth factors |
| 01/02/2014 | US20140005110 Platelet-derived growth factor compositions and methods for the treatment of tendinopathies |
| 01/02/2014 | US20140005108 Method for decreasing low density lipoprotein levels |
| 01/02/2014 | US20140005106 Method for administering glp-1 molecules |
| 01/02/2014 | US20140005105 Plasma anti-diabetic nucb2 peptide (pladin) and uses thereof |
| 01/02/2014 | US20140005104 Polyheterocyclic compounds highly potent as hcv inhibitors |
| 01/02/2014 | US20140005103 Sulfonamide derivatives and methods of use thereof for improving the pharmacokinetics of a drug |
| 01/02/2014 | US20140005096 Methods of treating inflammation |
| 01/02/2014 | US20140004603 Urocortin-iii and uses thereof |
| 01/02/2014 | US20140004198 Glp-1 particles and compositions |
| 01/02/2014 | US20140004196 Polyamide-amine dendrimer or derivative thereof-math1 gene nano particle and use thereof in treatment of hearing loss |
| 01/02/2014 | US20140004181 Compositions and methods for exosome targeted expression |
| 01/02/2014 | US20140004180 Topical compositions comprising diaminooxidase for the treatment or prevention of diseases associated with high histamine levels which involve an increase in pain |
| 01/02/2014 | US20140004179 Composition comprising diamine oxidase for use in the treatment or prevention of fibromyalgia or chronic fatigue syndrome |
| 01/02/2014 | US20140004175 Angiopoietin derived peptides |
| 01/02/2014 | US20140004173 Production of multivesicular liposomes |
| 01/02/2014 | US20140004172 Liposomes active in-vivo on neurodegenerative diseases |
| 01/02/2014 | US20140004136 Phosphorylated derivatives of a u1-70k peptide and their use in the treatment of autoimmune pathologies |
| 01/02/2014 | US20140004113 Defensin-antigen fusion proteins |
| 01/02/2014 | US20140004099 Dodecafluoropentane emulsion as a stroke and ischemia therapy |
| 01/02/2014 | US20140004098 Methods of treatment with elastase |
| 01/02/2014 | US20140004095 Albumin fusion proteins |
| 01/02/2014 | US20140004094 Compositions and methods for treating collagen-mediated diseases |
| 01/02/2014 | US20140004092 Cancer tumor encapsulation procedure |
| 01/02/2014 | US20140004081 Re-Directed Immunotherapy |
| 01/02/2014 | US20140004080 Use of low dose il-2 for treating autoimmune - related or inflammatory disorders |
| 01/02/2014 | US20140004077 Method for treating cervical cancer |
| 01/02/2014 | CA2877083A1 Biodegradable drug delivery for hydrophobic compositions |
| 01/01/2014 | EP2679598A1 T cell receptors and related materials and methods of use |
| 01/01/2014 | EP2679597A1 Glucagon-like peptide-1 derivatives and their pharmaceutical use |
| 01/01/2014 | EP2679270A1 Glp-1 analogue composition for microneedle devices |
| 01/01/2014 | EP2679246A2 Novel therapeutical tools and methods for treating blindness |
| 01/01/2014 | EP2679239A1 Pharmaceutical compound for treating the pulmonary form of altitude sickness caused by oxygen deprivation and reduced air pressure |
| 01/01/2014 | EP2679238A1 Methods of modulating the negative chemotaxis of immune cells |
| 01/01/2014 | EP2679237A1 Myostatin inhibition for enhancing muscle and/or improving muscle function |
| 01/01/2014 | EP2679236A1 Metering guide for lipopeptides that bind endotoxin |
| 01/01/2014 | EP2679235A2 Peptides and related molecules that modulate nerve growth factor activity |
| 01/01/2014 | EP2679234A2 Binding proteins that bind to human FGFR1C, human beta-klotho and both human FGFR1C and human beta-klotho |
| 01/01/2014 | EP2679217A1 Non-protein stabilized clostridial toxin pharmaceutical compositions |
| 01/01/2014 | EP2678679A1 Use of acetylated tubulin as a biomarker of drug response to furazanobenzimidazoles |
| 01/01/2014 | EP2678447A1 Cancer diagnosis and treatment |
| 01/01/2014 | EP2678361A2 Compositions with enhanced immunogenicity and/or reduced reactogenicity and methods of use |
| 01/01/2014 | EP2678360A1 Methods for treating and diagnosing disease |
| 01/01/2014 | EP2678354A1 Cardiac repair by reprogramming of cardiac fibroblasts into cardiomyocytes |
| 01/01/2014 | EP2678305A2 Chalcone derivatives as nrf2 activators |
| 01/01/2014 | EP2678043A2 Recombinant mumps virus vaccine |
| 01/01/2014 | EP2678029A1 Spray dried myrosinase and use to produce isothiocyanates |
| 01/01/2014 | EP2678028A2 Systems and methods for therapy of kidney disease and/or heart failure using chimeric natriuretic peptides |
| 01/01/2014 | EP2678027A1 Methods of identifying a patient population |
| 01/01/2014 | EP2678026A1 Ankyrin g and modulators thereof for the treatment of neurodegenerative disorders |
| 01/01/2014 | EP2678025A1 Therapeutic method for treating congestive heart failure |
| 01/01/2014 | EP2678024A1 Cutaneous pharmaceutical compositions for the local treatment of canine atopic dermatitis |
| 01/01/2014 | EP2678007A2 Protein nanocarriers for topical delivery |
| 01/01/2014 | EP2678005A2 Muc1 based glycolipopeptide vaccine with adjuvant |
| 01/01/2014 | EP2678002A2 Therapy for kidney disease and/or heart failure |
| 01/01/2014 | EP2677885A1 Protein hydrolysate compositions having enhanced cck and glp-1 releasing activity |
| 01/01/2014 | EP1682573B1 The use of eukaryotic genes affecting cell cycle control or cell cycle progression for diagnosis and treatment of proliferattive diseases |
| 01/01/2014 | CN103491977A Combination therapy for cancer |
| 01/01/2014 | CN103491976A Methods and compositions for treating conditions related to lack of blood supply, shock and neuronal injuries |
| 01/01/2014 | CN103491975A Combination of acylated glucagon analogues with insulin analogues |
| 01/01/2014 | CN103491974A Method for increasing neprilysin expression and activity |
| 01/01/2014 | CN103491973A Infant formula for use in the prevention of cardiovascular diseases |
| 01/01/2014 | CN103491967A Artificial saliva comprising hyaluronic acid |
| 01/01/2014 | CN103491966A Selection of HCV treatment |
| 01/01/2014 | CN103484519A Wheat protein peptide, preparation method and application thereof |
| 01/01/2014 | CN103484518A Walnut protein peptide, preparation method and application thereof |
| 01/01/2014 | CN103484517A Camellia seed protein peptide, preparation method and application thereof |
| 01/01/2014 | CN103484467A Diamondback moth cecropin 3, preparation method and application thereof |
| 01/01/2014 | CN103483453A Chimeric antigen receptor combining EGFR (epidermal growth factor receptor) family proteins and composition and uses thereof |
| 01/01/2014 | CN103483439A Alpha O-superfamily conotoxin peptide, and medicinal composition and use thereof |
| 01/01/2014 | CN103483433A Novel effective cerecidin and application thereof |
| 01/01/2014 | CN103483428A Small molecule-polypeptide conjugate capable of inhibiting HIV infection |
| 01/01/2014 | CN103483425A Taro protein extract with itch causing function and preparation method and application thereof |
| 01/01/2014 | CN103483418A DPP-IV inhibiting polypeptide and application thereof |
| 01/01/2014 | CN103480001A Acupoint massaging assisting preparation, preparation technology and application of preparation technology |
| 01/01/2014 | CN103479994A Activin-actriia antagonists and uses for promoting bone growth |
| 01/01/2014 | CN103479683A North cordyceps sinensis sporophores cultivated in large scale and health care and pharmaceutical application thereof |
| 01/01/2014 | CN103479607A Treating or preventing rotavirus infection |
| 01/01/2014 | CN103478733A Health-care oral liquid and preparation method thereof |
| 01/01/2014 | CN103478707A Insulin-like growth factor-I sustained release tablet and preparation method thereof |
| 01/01/2014 | CN103478346A Food blood nourishing tea electuary for treating alimentary anemia |
| 01/01/2014 | CN103055303B Composition capable of promoting differentiation of autologous preadipocytes and formation of lipid droplets and preparation method thereof |
| 01/01/2014 | CN102949711B Novel difunctional enzyme for promoting growth and development of bones and targeting abnormal development of bones |
| 01/01/2014 | CN102727420B D-glutamyl-D-tryptophan sodium colon targeting drug delivery agent and preparation method thereof |
| 01/01/2014 | CN102657871B Oral slow release preparation, entrapment material and preparation method |
| 01/01/2014 | CN102657849B Application of toad maggot protein in medicine used for treating cervical cancer |
| 01/01/2014 | CN102657848B Application of toad maggot protein in preparing medicine used for treating colon cancer |
| 01/01/2014 | CN102526715B Application of nereis virens protease in preparing medicament for treating leukocythemia |
| 01/01/2014 | CN102512662B Protein containing 36-83 amino acid motifs in Coxsackie B3virus 2B protein and application thereof |
| 01/01/2014 | CN102512661B Protein containing 1st to 79th sites of amino acid basic sequences in protein 2C of coxsackievirus B3 and application for same |
| 01/01/2014 | CN102512660B Protein containing 51st to 89th sites of amino acid basic sequences in protein 3A of coxsackievirus B3 and application for same |
| 01/01/2014 | CN102499379B Preparation technology for compound aquatic organism collagen peptide-calcium complex, technology for preparing calcium supplement from complex, and application of calcium supplement |
| 01/01/2014 | CN102488884B Thymopoietin for large dosage injection and application thereof for treating severe hepatitis |
| 01/01/2014 | CN102335416B Compound Chinese medicinal composition for treating hog cholera and preparation method thereof |